TrialLeukemia2018
A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia.
V Santini et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
50 papers cite it
this paperpooled ittrialcites it
TrialLeukemia2018
V Santini et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.